Seizure severity and health-related quality of life of adult Nigerian patients with epilepsy

Acta Neurologica Scandinavica

Volumn 129, Issue 2, 2014, Pages 102-108

  Adebayo, P B ^a,b   Akinyemi, R O ^c   Ogun, S A ^a   Ogunniyi, A ^d  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b Ladoke Akintola University Teaching Hospital   (Nigeria)

^c FEDERAL MEDICAL CENTER   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Adult; African; Epilepsy; Nigeria; Quality of life; Seizure severity

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; VALPROIC ACID;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL HOSPITAL SEIZURE SEVERITY SCALE; NIGERIA; ONSET AGE; QUALITY OF LIFE; QUALITY OF LIFE INVENTORY IN EPILEPSY; RISK FACTOR; SEIZURE; SOCIAL STATUS; TIME TO TREATMENT; URINE INCONTINENCE;

ADULT; AFRICAN; EPILEPSY; NIGERIA; QUALITY OF LIFE; SEIZURE SEVERITY;

ADULT; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; NIGERIA; QUALITY OF LIFE; QUESTIONNAIRES; SEIZURES; SEVERITY OF ILLNESS INDEX;

EID: 84891954158     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12146     Document Type: Article

References (26)

1. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.
2. Nubukpo P, Clément JP, Houinato D et al. Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) II: quality of life measured using the QOLIE-31 scale. Epilepsy Behav 2004;5:728-34.
3. Imam I, Talabi OA, Sanya EO, Ogunniyi A. The quality of life of chronic epileptics in Ibadan, Nigeria. Afr J Med Med Sci 2003;32:367-9.
4. Mosaku KS, Fatoye FO, Komolafe M, Lawal M, Ola BA. Quality of Life and associated factors among adults with epilepsy in Nigeria. Int J Psychiatry Med 2006;36:469-81.
5. Fawale MB. Health related quality of life of adult patients with epilepsy in Ibadan. A Dissertation submitted to the National postgraduate medical college of Nigeria, Nov, 2008.
6. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258-61.
7. Olley BO. Psychosocial and seizure factors related to depression and neurotic-disorders among patients with chronic epilepsy in Nigeria. Afr J Med Med Sci 2004;33:39-44.
8. Cramer JA, Blum D, Reed M, Fanning K. The influence of comorbid depression on seizure severity. Epilepsia 2003;44:1578-84.
9. Bautista RE, Glen ET. Seizure severity is associated with quality of life independent of seizure frequency. Epilepsy Behav 2009;16:325-9.
10. Vickrey BG, Berg AT, Sperling MR et al. Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000;41:760-4.
11. Harden CL, Maroof DA, Nikolov B et al. The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav 2007;11:208-11.
12. Aydemir N. Developing two different measures to assess knowledge of epilepsy and attitudes toward epilepsy for Turkish population. Epilepsy Behav 2008;12:84-9.
13. Imam I, Talabi OA, Sanya EO, Ogunniyi A. The determinants of seizure severity in Nigerian epileptics. NigerJ Clin Pract 2005;8:94-6.
14. Commission on Classification and Terminology. International League Against Epilepsy. Proposed revisions of clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:480-501.
15. O'Donoghue MF, Duncan JS, Sander JWAS. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 1996;375:63-71.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
17. Hwang S, Ettinger A, So EL. Epilepsy comorbidities. Continuum (Minneap Minn) 2010;16:86-104.
18. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007;75:192-6.
19. Cramer JA, Blum D, Fanning K, Reed M; Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004;5:337-42.
20. Kerr MP. The impact of epilepsy on patients' lives. Acta Neurol Scand Suppl 2012;194:1-9.
21. Baker GA, Camfield C, Camfield P et al. Commission on outcome measurement in epilepsy, 1994-1997: final report. Epilepsia 1998;39:213-31.
22. Birbeck GL, Hays RD, Cui X, Vickrey BG. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002;43:535-8.
23. Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia 1997;38(Suppl 1):S1-8.
24. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58:S9-20.
25. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:23-7.
26. Selai C, Bannister D, Trimble M. Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy. Epilepsia 2005;46(Suppl 4):50-7.